APO RESEARCH · REPORT
Biodefense
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
Product & engineering
Understand the product.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
Selected research
Market Structure
Global Biodefense Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
Read the full market overview
Report Includes
This report provides an overview of the global Biodefense market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biodefense and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biodefense revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biodefense market size, projected growth trends, production technologies, key applications, and end-use industries.
Biodefense Segment by Company
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Biodefense Segment by Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Biodefense Segment by Application
US Military Market
US Civilian Market
Non - US Market
Biodefense Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodefense market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodefense and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodefense.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biodefense in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biodefense industry.
Chapter 3: Detailed analysis of Biodefense companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biodefenserevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
Applications
- US Military Market
- US Civilian Market
- Non - US Market
Companies covered
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biodefense Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Anthrax
- 1.2.3 Smallpox
- 1.2.4 Botulism
- 1.2.5 Radiation/Nuclear
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Biodefense Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 US Military Market
- 1.3.3 US Civilian Market
- 1.3.4 Non - US Market
- 1.4 Global Market Growth Prospects
- 1.5 Global Biodefense Growth Trends by Region
- 1.5.1 Global Biodefense Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biodefense Market Size by Region (2021-2026)
- 1.5.3 Biodefense Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biodefense Market Dynamics
- 2.1 Biodefense Industry Trends
- 2.2 Biodefense Industry Drivers
- 2.3 Biodefense Industry Opportunities and Challenges
- 2.4 Biodefense Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biodefense Revenue by Company (2021-2026)
- 3.2 Global Biodefense Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biodefense Key Company Head office and Area Served
- 3.4 Global Biodefense Company, Product Type & Application
- 3.5 Global Biodefense Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biodefense Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biodefense Players Market Share by Revenue in 2025
- 3.6.3 2025 Biodefense Tier 1, Tier 2, and Tier 3
4 Biodefense Market by Type
- 4.1 Global Biodefense Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biodefense Market Size by Type (2021-2032)
- 4.3 Global Biodefense Market Size Share by Type (2021-2032)
5 Biodefense Market by Application
- 5.1 Global Biodefense Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biodefense Market Size by Application (2021-2032)
- 5.3 Global Biodefense Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Emergent Biosolutions
- 6.1.1 Emergent Biosolutions Company Information
- 6.1.2 Emergent Biosolutions Business Overview
- 6.1.3 Emergent Biosolutions Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Emergent Biosolutions Biodefense Product Portfolio
- 6.1.5 Emergent Biosolutions Recent Developments
- 6.2 Hytest
- 6.2.1 Hytest Company Information
- 6.2.2 Hytest Business Overview
- 6.2.3 Hytest Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Hytest Biodefense Product Portfolio
- 6.2.5 Hytest Recent Developments
- 6.3 GSK
- 6.3.1 GSK Company Information
- 6.3.2 GSK Business Overview
- 6.3.3 GSK Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GSK Biodefense Product Portfolio
- 6.3.5 GSK Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sanofi Biodefense Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 PharmAthene
- 6.5.1 PharmAthene Company Information
- 6.5.2 PharmAthene Business Overview
- 6.5.3 PharmAthene Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PharmAthene Biodefense Product Portfolio
- 6.5.5 PharmAthene Recent Developments
- 6.6 Bavarian Nordic
- 6.6.1 Bavarian Nordic Company Information
- 6.6.2 Bavarian Nordic Business Overview
- 6.6.3 Bavarian Nordic Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bavarian Nordic Biodefense Product Portfolio
- 6.6.5 Bavarian Nordic Recent Developments
- 6.7 SIGA Technologies
- 6.7.1 SIGA Technologies Company Information
- 6.7.2 SIGA Technologies Business Overview
- 6.7.3 SIGA Technologies Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SIGA Technologies Biodefense Product Portfolio
- 6.7.5 SIGA Technologies Recent Developments
- 6.8 Arbutus Biopharma
- 6.8.1 Arbutus Biopharma Company Information
- 6.8.2 Arbutus Biopharma Business Overview
- 6.8.3 Arbutus Biopharma Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Arbutus Biopharma Biodefense Product Portfolio
- 6.8.5 Arbutus Biopharma Recent Developments
- 6.9 DynPort Vaccine
- 6.9.1 DynPort Vaccine Company Information
- 6.9.2 DynPort Vaccine Business Overview
- 6.9.3 DynPort Vaccine Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 DynPort Vaccine Biodefense Product Portfolio
- 6.9.5 DynPort Vaccine Recent Developments
- 6.10 Xoma Corporation
- 6.10.1 Xoma Corporation Company Information
- 6.10.2 Xoma Corporation Business Overview
- 6.10.3 Xoma Corporation Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Xoma Corporation Biodefense Product Portfolio
- 6.10.5 Xoma Corporation Recent Developments
- 6.11 Ichor Medical Systems
- 6.11.1 Ichor Medical Systems Company Information
- 6.11.2 Ichor Medical Systems Business Overview
- 6.11.3 Ichor Medical Systems Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Ichor Medical Systems Biodefense Product Portfolio
- 6.11.5 Ichor Medical Systems Recent Developments
- 6.12 Aeolus Pharmaceuticals
- 6.12.1 Aeolus Pharmaceuticals Company Information
- 6.12.2 Aeolus Pharmaceuticals Business Overview
- 6.12.3 Aeolus Pharmaceuticals Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Aeolus Pharmaceuticals Biodefense Product Portfolio
- 6.12.5 Aeolus Pharmaceuticals Recent Developments
- 6.13 Achaogen
- 6.13.1 Achaogen Company Information
- 6.13.2 Achaogen Business Overview
- 6.13.3 Achaogen Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Achaogen Biodefense Product Portfolio
- 6.13.5 Achaogen Recent Developments
- 6.14 Elusys Therapeutics
- 6.14.1 Elusys Therapeutics Company Information
- 6.14.2 Elusys Therapeutics Business Overview
- 6.14.3 Elusys Therapeutics Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Elusys Therapeutics Biodefense Product Portfolio
- 6.14.5 Elusys Therapeutics Recent Developments
- 6.15 Dynavax Technologies
- 6.15.1 Dynavax Technologies Company Information
- 6.15.2 Dynavax Technologies Business Overview
- 6.15.3 Dynavax Technologies Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Dynavax Technologies Biodefense Product Portfolio
- 6.15.5 Dynavax Technologies Recent Developments
- 6.16 Cleveland BioLabs
- 6.16.1 Cleveland BioLabs Company Information
- 6.16.2 Cleveland BioLabs Business Overview
- 6.16.3 Cleveland BioLabs Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Cleveland BioLabs Biodefense Product Portfolio
- 6.16.5 Cleveland BioLabs Recent Developments
- 6.17 Soligenix
- 6.17.1 Soligenix Company Information
- 6.17.2 Soligenix Business Overview
- 6.17.3 Soligenix Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Soligenix Biodefense Product Portfolio
- 6.17.5 Soligenix Recent Developments
- 6.18 Alnylam Pharmaceuticals
- 6.18.1 Alnylam Pharmaceuticals Company Information
- 6.18.2 Alnylam Pharmaceuticals Business Overview
- 6.18.3 Alnylam Pharmaceuticals Biodefense Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Alnylam Pharmaceuticals Biodefense Product Portfolio
- 6.18.5 Alnylam Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Biodefense Market Size (2021-2032)
- 7.2 North America Biodefense Market Size by Type
- 7.2.1 North America Biodefense Market Size by Type (2021-2026)
- 7.2.2 North America Biodefense Market Size by Type (2027-2032)
- 7.2.3 North America Biodefense Market Share by Type (2021-2032)
- 7.3 North America Biodefense Market Size by Application
- 7.3.1 North America Biodefense Market Size by Application (2021-2026)
- 7.3.2 North America Biodefense Market Size by Application (2027-2032)
- 7.3.3 North America Biodefense Market Share by Application (2021-2032)
- 7.4 North America Biodefense Market Size by Country
- 7.4.1 North America Biodefense Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biodefense Market Size by Country (2021-2026)
- 7.4.3 North America Biodefense Market Size by Country (2027-2032)
- 7.4.4 North America Biodefense Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biodefense Market Size (2021-2032)
- 8.2 Europe Biodefense Market Size by Type
- 8.2.1 Europe Biodefense Market Size by Type (2021-2026)
- 8.2.2 Europe Biodefense Market Size by Type (2027-2032)
- 8.2.3 Europe Biodefense Market Share by Type (2021-2032)
- 8.3 Europe Biodefense Market Size by Application
- 8.3.1 Europe Biodefense Market Size by Application (2021-2026)
- 8.3.2 Europe Biodefense Market Size by Application (2027-2032)
- 8.3.3 Europe Biodefense Market Share by Application (2021-2032)
- 8.4 Europe Biodefense Market Size by Country
- 8.4.1 Europe Biodefense Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biodefense Market Size by Country (2021-2026)
- 8.4.3 Europe Biodefense Market Size by Country (2027-2032)
- 8.4.4 Europe Biodefense Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biodefense Market Size (2021-2032)
- 9.2 China Biodefense Market Size by Type
- 9.2.1 China Biodefense Market Size by Type (2021-2026)
- 9.2.2 China Biodefense Market Size by Type (2027-2032)
- 9.2.3 China Biodefense Market Share by Type (2021-2032)
- 9.3 China Biodefense Market Size by Application
- 9.3.1 China Biodefense Market Size by Application (2021-2026)
- 9.3.2 China Biodefense Market Size by Application (2027-2032)
- 9.3.3 China Biodefense Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biodefense Market Size (2021-2032)
- 10.2 Asia Biodefense Market Size by Type
- 10.2.1 Asia Biodefense Market Size by Type (2021-2026)
- 10.2.2 Asia Biodefense Market Size by Type (2027-2032)
- 10.2.3 Asia Biodefense Market Share by Type (2021-2032)
- 10.3 Asia Biodefense Market Size by Application
- 10.3.1 Asia Biodefense Market Size by Application (2021-2026)
- 10.3.2 Asia Biodefense Market Size by Application (2027-2032)
- 10.3.3 Asia Biodefense Market Share by Application (2021-2032)
- 10.4 Asia Biodefense Market Size by Country
- 10.4.1 Asia Biodefense Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biodefense Market Size by Country (2021-2026)
- 10.4.3 Asia Biodefense Market Size by Country (2027-2032)
- 10.4.4 Asia Biodefense Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biodefense Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biodefense Market Size by Type
- 11.2.1 South America, Middle East & Africa Biodefense Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biodefense Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biodefense Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biodefense Market Size by Application
- 11.3.1 South America, Middle East & Africa Biodefense Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biodefense Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biodefense Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biodefense Market Size by Country
- 11.4.1 South America, Middle East & Africa Biodefense Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biodefense Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biodefense Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biodefense Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst